乳腺癌是危害女性健康的主要恶性肿瘤之一,在我国位居女性恶性肿瘤的首位或第二位。随着个体化诊疗方案的提出,要求病理工作者能够针对不同人群、不同临床标本做出准确而快速的诊断。由于部分乳腺癌患者不能耐受手术,难以取得活检组织,故无法做出病理分型而影响治疗。薄层液基细胞技术最早用于女性宫颈癌筛查,但随着该技术的不断完善,目前已被广泛应用于细胞学诊断,如淋巴穿刺液、腹腔穿刺液、支气管针吸细胞等。本文采用已确诊的乳 Breast cancer is one of the major malignant tumors that endanger the health of women, ranking the first or second place in China for female malignant tumors. With the individualized diagnosis and treatment plan put forward, pathologists are required to make accurate and rapid diagnosis for different people and different clinical specimens. Because some patients with breast cancer can not tolerate surgery, it is difficult to obtain biopsy, it can not make the pathological classification and treatment. Thin-layer liquid-based cell technology was first used for cervical cancer screening in women, but with the continuous improvement of the technology, it has been widely used in cytological diagnosis, such as lymphatic fluid, abdominal puncture fluid and bronchial needle aspiration cells. This article has been diagnosed with milk